Accès rapides :

Vous êtes ici :

  1. Accueil
  2. Publications et outils
  3. Bases de données
  4. Fiches toxicologiques
  5. Nicotine (FT 312) (rubrique sélectionnée)

Nicotine

Fiche toxicologique n° 312

Sommaire de la fiche
Fiche complète (PDF 222,53 Ko) Fiche synthétique (PDF 77 Ko)
Nouvelle recherche

Édition : Février 2018

Bibliographie

  1. Rapport d’expertise collective, saisine n°2014-SA-0130 - Evaluation des dangers de la nicotine. ANSES, 2015 (www.anses.fr).
  2. Bingham E, Cohrssen B – Patty’s toxicology, 6e éd., Vol. 2. New York : John Wiley and sons ; 2012: pp. 817-822.
  3. Nicotine. In: International Programme on Chemical Safety (IPCS) Inchem (http://www.inchem.org/).
  4. Nicotine. In: Répertoire toxicologique. CSST, 2014. (www.reptox.csst.qc.ca/)
  5. Nicotine. In: The Merck index. An encyclopedia of chemicals, drugs, and biologicals. 14th edition. Whitehouse Station : Merck and Co ; 2006.
  6. Nicotine. In: Gestis-databank on hazardous substances. BGIA, 2012 (www.dguv.de/ifa/gestis-database/index.jsp).
  7. Nicotine - In : Guide to Occupational Exposure Values. ACGIH, 2001.
  8. Nicotine – Aide-mémoire technique "Les valeurs limites d'exposition professionnelles aux agents chimiques". ED n° 984. INRS (www.inrs.fr).
  9. Nicotine. In : Gestis International Limit Values (http://limitvalue.ifa.dguv.de/).
  10. Nicotine. Method 2551. In: NIOSH Manual of Analytical Methods (NMAM), 4th edition. NIOSH, 1998 (www.cdc.gov/niosh/nmam).
  11. Airborne Nicotine Concentrations in the Workplaces of Tobacco Farmers. Seok-Ju Yoo, Sung-Jun Park, Byoung-Seok Kim, Kwan Lee, Hyun-Sul Lim, Jik-Su Kim, In-Shik Kim. J. Prev Med Public Health. 2014; 47:144-149
  12. An Assessment of Indoor Air Quality before, during and after Unrestricted Use of E-Cigarettes in a Small Room; Grant O’Connell 1, Stéphane Colard 2, Xavier Cahours 2 and John D. Pritchard 3,* Int. J. Environ. Res. Public Health. 2015, 12, 4889-4907;
  13. Monitoring of nicotine in air using sorptive enrichment on polydimethylsiloxane and TD-CGC-NPD. Chromatographia. May 1999, Volume 49, Issue 9, pp 520-524
  14. Nicotine. Method 2544. In: NIOSH Manual of Analytical Methods (NMAM), 4th edition. NIOSH, 1994 (www.cdc.gov/niosh/nmam)
  15. Airborne Nicotine Concentrations in the Workplaces of Tobacco Farmers. Seok-Ju Yoo1, Sung-Jun Park1, Byoung-Seok Kim1, Kwan Lee1, Hyun-Sul Lim1, Jik-Su Kim2, In-Shik Kim3 J Prev Med Public Health 2014;47:144-149
  16. Kim KY, Le Y-J, Chung BC et al. – Relations between toxicity and altered tissue distribution and urinary excretion of nicotine, cotinine and hydroxycotinine after chronic oral administration of nicotine in rats. Drug Chem Toxicol. 2010 ; 33(2) : 166-172.
  17. Shah PV, Monroe RJ et Guthrie FE – Comparative rates of dermal penetration of insecticides in mice. Toxicol Appl Pharmacol. 1981 ; 59 : 414-423.
  18. Benowitz NL, Jacob P et Savanapridi C - Determinants of nicotine intake while chewing nicotine polacrilex gum. Clin Pharmacol Ther. 1987 ; 41 : 467-473.
  19. Potential risks for public health due to the presence of nicotine in wild mushrooms. EFSA Statement. The EFSA journal. 2009 ; RN-286 : 1-47.
  20. Benowitz NL, Hukkanen J et Jacob - Nicotine Chemistry, Metabolism, Kinetics and Biomarkers. Hand Exp Pharmacol. 2009 ; 192 : 29–60.
  21. Smokeless tobacco and some tobacco specific N-nitrosamines. IARC Monographs of the Evaluation of Carcinogenic Risks to Humans. Vol. 89, IARC; 2007 (http://monographs.iarc.fr).
  22. Nicotine - Opinion proposing harmonized classification and labeling at EU level. RAC ; Echa, 2015.
  23. Freeman GB, Sherman KA et Gibson GE – Locomotor activity as a predictor of times and dosages for studies of nicotine’s neurochemical actions. Pharmacol Biochem Behav. 1987 ; 26 : 305-312.
  24. Nicotine - Dossier d’enregistrement REACH (echa.europa.eu/).
  25. Yuen ST, Gogo AR, Luk ISC et al. – The effect of nicotine and its interaction with carbon tetrachloride in the rat liver. Pharmacol Toxicol. 1995 ; 77 : 225-230.
  26. Dodmane PR, Arnold LL, Pennington KL et Cohen SM – Orally administered nicotine induces urothelial hyperplasia in rats and mice. Toxicologyl. 2014 ; 315 : 49-54.
  27. Fahim MA, Nemmar A, Al-Salam S et al. – Thromboembolic injury and systemic toxicity induced by nicotine in mice. Gen Physiol Biophys.  2014 ; 33(3) : 345-355.
  28. Kallala R, Barrow J, Graham SM et al. – The in vitro and in vivo effects of nicotine on bone, bone cells and fracture repair. Expert Opin Drug Saf. 2013 ; 12(2) : 209-233.
  29. Levin ED, Morgan MM, Galvez C et Ellison GD – Chronic nicotine and withdrawal effects on body weight and food and water consumption in female rats. Physiol Behav. 1987 ; 39 : 441-444.
  30. Carroll ME, Lac ST, Ascencio M et Keenan RM - Nicotine dependence in rats. Life Sci. 1989 ; 45 : 1381-1388.
  31. Galitovskiy V, Chernyavsky AI, Edwards RA et Grando SA – Muscle sarcomas and alopecia in A/J mice chronically treated with nicotine. Life Sci. 2012 ; 91(21-22) : 1109-1112.
  32. Nicotine. In: HSBD. NLM, consulté en septembre 2015 (toxnet.nlm.nih.gov/cgi-bin/sis/htmlgen?HSDB).
  33. Witschi H, Lundgaard SM, Rajini P et al – Effects of exposure to nicotine and to sidestream smoke on pregnancy outcome in rats. Toxicol Lett. 1994 ; 71 : 279-286.
  34. Mohsenzadeh Y, Rahmani A, Cheragi J et al. – Prenatal exposure to nicotine in pregnant rat increased inflammatory marker in newborn rat. Mediator Inflamm. 2014 ; 5 pp.
  35. Ma N, Nicholson CJ, Wong M et al. – Fetal and neonatal exposure to nicotine leads to augmented hepatic and circulating triglycerids in adult male offspring due to increased expression of fatty acid synthase. Toxicol Appl Pharmacol. 2014 ; 275 : 1-11.
  36. Tweed JO, Hsia SH, Lutfy K, Friedman TC. The endocrine effects of nicotine and cigarette smoke. Trends in Endocrinology & Metabolism. 23(7) ; 2012 : 334-342.
  37. Wong MK, Barra NG, Alfaidy N, Hardy DB et al. Adverse effects of perinatal nicotine exposure on reproductive outcomes.Reproduction. 150(6) ; 2015 : R185-R193.
  38. Alkam T et al. – Evaluation of cognitive behaviors in young offspring of C57BL/6J mice after gestational nicotine exposure during different time-windows. Psychopharmacol. 2013 ; 230(3) : 451-463.
  39. Mayer B. How much nicotine kills a human? Tracing back the generally accepted lethal dose to dubious self-experiments in the nineteenth century. Arch Toxicol. 88 ; 2014 : 5-7.
  40. Lavoie FW, Harris TM. Fatal nicotine ingestion. The Journal of emergency medicine. 9(3), 1991 : 133-36.
  41. Schipper EM, De Graaff LCG, Koch BCP, Brkic Z et al. A new challenge: suicide attempt using nicotine fillings for electronic cigarettes. British Journal of Clinical Pharmacology. 78; 2014 : 1469–71.
  42. Sommerfeld K, Łukasik-Głębocka M, Kulza M, Drużdż A et al. Intravenous and oral suicidal e-liquid poisonings with confirmed nicotine and cotinine concentrations. Forensic science international. 262 ; 2016 : e15-e20.
  43. Cantrell FL, Clark RF. More on Nicotine Poisoning in Infants. N Engl J Med. 371(9) ; 2014 : 880.
  44. Nicotine (ISO); 3-[(2S)-1-methylpyrrolidin-2-yl]pyridine. CLH Report. ECHA, 2015 (www.echa.eu).
  45. Draft Assessment Report (DAR) of Nicotine, soumis par le Royaume Uni, 4 novembre 2008 (Règlement 91/414/ CE).
  46. Fassa AG, Faria NM, Meucci RD, Fiori NS et al. Green tobacco sickness among tobacco farmers in southern Brazil. American journal of industrial medicine. 57(6) ; 2014 : 726-35.
  47. Rapport et avis d’experts sur l’e-cigarette. Office français de prévention du tabagisme. 2013. (https://www.federationaddiction.fr/rapport-et-avis-dexperts-sur-le-cigarette/)
  48. Benowitz NL, Burbank AD. Cardiovascular toxicity of nicotine: Implications for electronic cigarette use. Trends in Cardiovascular Medicine. Available online 10 March 2016.
  49. Nicotine. Skin notation. NIOSH. 2013.
  50. Benowitz  NL, Jacob P and Herrera B. Nicotine intake and dose response when smoking reduced–nicotine content cigarettes. Clinical Pharmacology & Therapeutics. 80 ; 2006 : 703–14.
  51. Papathanasiou G, Mamali A, Papafloratos S, Zerva E. Effects of smoking on cardiovascular function: the role of nicotine and carbon monoxide. Health Science Journal. 8(2) ; 2014 : 274-90.
  52. Lassen TH, Madsen M, Skovgaard LT, Strandberg‐Larsen K et al. Maternal use of nicotine replacement therapy during pregnancy and offspring birthweight: a study within the Danish National Birth Cohort. Paediatric and perinatal epidemiology, 24(3) ; 2010 : 272-81.
  53. Coleman T, Cooper S, Thornton JG, Grainge MJ et al. A randomized trial of nicotine-replacement therapy patches in pregnancy. New England Journal of Medicine. 366(9) ; 2012 : 808-18.
  54. Coleman T, Chamberlain C, Davey MA, Cooper SE et al. Pharmacological interventions for promoting smoking cessation during pregnancy. Cochrane Database Syst Rev. 9 (9) ; 2015.
  55. Dhalwani NN, Szatkowski L, Coleman T, Fiaschi L et al. Nicotine replacement therapy in pregnancy and major congenital anomalies in offspring. Pediatrics. 135 (5) ; 2015 : 859-67.
  56. Campo L, Polledri E, Bechtold P, Gatti G et al. Determinants of active and environmental exposure to tobacco smoke and upper reference value of urinary cotinine in not exposed individuals, Env Research, 2016 : 148, 154-163.
  57. Forsberg K, Van Den Borre A, Henry III N et Zeigler JP – Quick selection guide to chemical protective clothing. 6th ed. Hoboken : John Wiley & Sons ; 2014 : 260 p.
  58. Cuves et réservoirs - Recommandation CNAMTS R 435. Paris : INRS ; 2008.
Nouvelle recherche
EN SAVOIR PLUS SUR LES FICHES TOXICOLOGIQUES